Last 1,235 INR
Change Today +3.95 / 0.32%
Volume 11.1K
PFIZ On Other Exchanges
Symbol
Exchange
Natl India
As of 7:32 AM 04/17/14 All times are local (Market data is delayed by at least 15 minutes).

pfizer limited (PFIZ) Snapshot

Open
1,232
Previous Close
1,231
Day High
1,260
Day Low
1,228
52 Week High
12/2/13 - 1,779
52 Week Low
07/29/13 - 963.89
Market Cap
36.8B
Average Volume 10 Days
29.5K
EPS TTM
45.95
Shares Outstanding
29.8M
EX-Date
12/5/13
P/E TM
26.9x
Dividend
360.00
Dividend Yield
31.79%
Current Stock Chart for PFIZER LIMITED (PFIZ)

Related News

No related news articles were found.

pfizer limited (PFIZ) Related Businessweek News

No Related Businessweek News Found

pfizer limited (PFIZ) Details

Pfizer Limited provides various pharmaceutical products in India and internationally. The company offers products in the areas of anti-infectives, anti-fungal, anti-TB, neuropathic pain, antifibrinolytic, dermatology, dyslipidemia, gastrointestinal, GI–hyperacidity, GERD, gynecology, immune enhancer, inflammation, multi-vitamin, neurology, nutraceutical, ophthalmology, otology, respiratory, trichology, urinary alkanizer, urology, and cardiovascular, including hypertension, acidity, smoking cessation, and angina. Its Pharmaceuticals segment manufactures and trades in formulations, as well as provides marketing services. The company’s Services segment is involved in clinical development operations, which primarily include conducting clinical trials, new product development, and undertaking data management for drug development. Pfizer Limited was incorporated in 1950 and is headquartered in Mumbai, India.

2,795 Employees
Last Reported Date: 05/14/13
Founded in 1950

pfizer limited (PFIZ) Top Compensated Officers

Managing Director, Additional Director and Me...
Total Annual Compensation: 17.6M
Executive Director of Technical Operations, W...
Total Annual Compensation: 8.0M
Compensation as of Fiscal Year 2013.

pfizer limited (PFIZ) Key Developments

Pfizer Limited, Annual General Meeting, Apr 16, 2014

Pfizer Limited, Annual General Meeting, Apr 16, 2014., at 15:00 Indian Standard Time. Location: Yashwantrao Chavan Pratishthan Auditorium. Agenda: To approve the scheme of amalgamation between Wyeth Limited and Pfzier limited and their respective shareholders and creditors.

Pfizer Limited Reports Unaudited Standalone Earnings Results for the Third Quarter and Nine Months Ended December 31, 2013

Pfizer Limited reported unaudited standalone earnings results for the third quarter and nine months ended December 31, 2013. For the quarter, the company reported net sales/income from operations net of excise duty of INR 2,477.0 million against INR 2,297.8 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 446.6 million against INR 378.9 million a year ago. Profit from ordinary activities before tax was INR 727.1 million against INR 958.2 million a year ago. Profit from ordinary activities after tax was INR 476.0 million against INR 638.8 million a year ago. Basic and diluted earnings per share after exceptional items were INR 15.95 against diluted earnings per share after exceptional items of INR 21.41 a year ago. For the nine months, the company reported net sales/income from operations net of excise duty of INR 7,525.8 million against INR 6,957.9 million a year ago. Profit from operations before other income, finance costs and exceptional items was INR 1,596.8 million against INR 1,217.1 million a year ago. Profit from ordinary activities before tax was INR 2,525.8 million against INR 6,096.4 million a year ago. Profit from ordinary activities after tax was INR 1,648.2 million against INR 4,450.4 million a year ago. Basic and diluted earnings per share after exceptional items were INR 55.23 against diluted earnings per share after exceptional items of INR 149.14 a year ago.

Pfizer Limited to Report Q3, 2014 Results on Jan 31, 2014

Pfizer Limited announced that they will report Q3, 2014 results on Jan 31, 2014

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PFIZ:IN 1,234.80 INR +3.95

PFIZ Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Abbott India Ltd 1,774 INR -8.55
Array BioPharma Inc $3.79 USD -0.05
Dendreon Corp $2.65 USD -0.0401
Merit Medical Systems Inc $13.06 USD -0.37
Spectrum Pharmaceuticals Inc $6.77 USD -0.11
View Industry Companies
 

Industry Analysis

PFIZ

Industry Average

Valuation PFIZ Industry Range
Price/Earnings 16.8x
Price/Sales 3.4x
Price/Book 2.1x
Price/Cash Flow 16.2x
TEV/Sales 2.0x
 | 

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact PFIZER LIMITED, please visit www.pfizerindia.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.